Budesonide

布地奈德

Report date: 2026/05/22 20:01:29
NME

Base Information

Drug NameBudesonide
Drug Alias NameBudesonidumBudesonide multimatrixBudesonide controlled releaseBudesolvNefecon (布地奈德) +[47] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Chronic rhinosinusitis with nasal polyps (CRSwNP)Respiratory Sounds +[43] 
Global Approved IndicationsSkin DiseasesGlomerulonephritis, IGARhinitis, Allergic, Seasonal +[9] 
Approved Indications in ChinaRhinitis, Allergic, SeasonalRhinitis, Allergic, PerennialNasal Polyps
Original Approved Country/TerritoryN/A
Original Approved Date1981/01/01
Country/TerritoryCzechiaBelgiumBulgaria +[50] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAbbott LaboratoriesUnither Pharmaceuticals, FranceUtah State University +[29] 
Inactive CompaniesWyeth LlcShireActivaero Gmbh +[43] 
Active IndicationsChronic rhinosinusitis with nasal polyps (CRSwNP)Puberty, PrecociousSkin Diseases +[20] 
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory SoundsDiarrhea +[23] 

Other Information

ATC CodeA07EA06D07AC09R01AD05 +[4] 
Related LinksWikipediaDrugBankKEGG